SCHEMBL21282158

SCHEMBL21282158

COc1ccc(Nc2ccc3cc(O)ccc3n2)cn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FYN P06241 3/20 0.50
▸ PIK3CA P42336 5/20 0.47
▸ MAPK8 P45983 1/20 0.47
▸ MAPK9 P45984 1/20 0.47
▸ MAPK10 P53779 1/20 0.47
▸ MEN1 O00255 5/20 0.46
▸ KMT2A Q03164 5/20 0.46
▸ PABPC1 P11940 3/20 0.46
▸ SRC P12931 2/20 0.45
▸ PIK3CD O00329 2/20 0.45
▸ PIK3CB P42338 2/20 0.45
▸ KDM4E B2RXH2 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ KEAP1 Q14145 1/20 0.41
▸ NFE2L2 Q16236 1/20 0.41
▸ USP2 O75604 1/20 0.41
▸ TNIK Q9UKE5 1/20 0.40
▸ HSD17B1 P14061 1/20 0.40
▸ HSD17B2 P37059 1/20 0.40
▸ ACP1 P24666 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21282210 0.86 KMT2A (0.47) FYNPIK3CAMAPK8MAPK9MAPK10
SCHEMBL21282159 0.86 FYN (0.49) FYNPIK3CAMAPK8MAPK9MAPK10
SCHEMBL21282189 0.85 MEN1 (0.46) FYNPIK3CAMAPK8MAPK9MAPK10
SCHEMBL21282171 0.85 MEN1 (0.46) FYNPIK3CAMAPK8MAPK9MAPK10
SCHEMBL21282214 0.81 PIK3CA (0.47) FYNPIK3CAMAPK8MAPK9MAPK10
SCHEMBL21282217 0.80 MEN1 (0.69) PIK3CAMAPK8MAPK9MAPK10MEN1
SCHEMBL21282160 0.79 MAPT (0.44) FYNPIK3CAMAPK8MAPK9MAPK10
SCHEMBL21282177 0.76 MEN1 (0.48) FYNPIK3CAMAPK8MAPK9MAPK10
SCHEMBL21282164 0.76 PIK3CA (0.43) FYNPIK3CAMAPK8MAPK9MAPK10
SCHEMBL1238150 0.75 ESR1 (0.50) KDM4EHSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190256492-A1 ALPHA-SYNUCLEIN LIGANDS WASHINGTON UNIVERSITY (US) 2019-08-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190256492-A1 ALPHA-SYNUCLEIN LIGANDS SNCA, PARK7, LRRK2 FYN 795/4885PIK3CA 4043/4885MAPK8 3908/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback